Who we are
A preclinical provider in otology, we are uniquely qualified in the functions of the ear, a complex sensory organ which remains under-explored. Established in Boston, Paris, Montpellier, and Copenhagen, we have state-of-the art laboratories, research experts in otology and neurosciences, as well as a global network of partners. This enables us to offer fully customizable and comprehensive R&D programs including pharmacokinetics, preclinical efficacy, and GLP ototoxicity studies.
Our talented team is deeply committed to its mission: “To accelerate the development of novel therapies to prevent and treat hearing loss, tinnitus, and otitis, in order to provide solutions to millions of patients suffering from ear diseases, waiting for effective treatment.”
Drawing on our extensive industrial background, we also provide consultancy services to speed up your product’s R&D cycle time. CILcare works with academic research centers, private companies operating in pharmaceuticals, medical devices, nutraceuticals, and animal health, as well as patient associations and venture capital funds. A trusted CRO partner with the ambition to catalyze research & development in hearing disorders on a global scale, join us as we fight for this cause:
The care of this extraordinary sense: hearing.